3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Biphenotypic, Acute
3
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid
2
Leukemia, Lymphoid
2
Burkitt Lymphoma
2
Preleukemia
1
Precancerous Conditions
1
Neoplasms by Histologic Type
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoproliferative Disorders
1
Lymphoma, Primary Effusion
1
Lymphatic Diseases
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Monocytic, Acute
1
Leukemia, Mast-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Leukemia
1
Immunoproliferative Disorders
1
Immune System Diseases
1
Hematologic Neoplasms
1
Hematologic Diseases
1
GATA2 Deficiency
1
Bone Marrow Diseases
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Interventions
Cyclophosphamide
13
Temozolomide
10
Magnetic Resonance Spectroscopy
10
dinutuximab
8
X-Rays
8
Specimen Handling
8
Irinotecan
8
Biopsy
8
Phantoms, Imaging
7
Topotecan
6
Nuclear Medicine Department, Hospital
6
fludarabine
5
Vincristine
5
3-Iodobenzylguanidine
5
fludarabine phosphate
4
Granulocyte-Macrophage Colony-Stimulating Factor
4
Etoposide
4
tipifarnib
3
sargramostim
3
Radiotherapy
3
Melphalan
3
Isotretinoin
3
Filgrastim
3
Doxorubicin
3
Carboplatin
3
ulixertinib
2
tazemetostat
2
selpercatinib
2
saponin QA-21V1
2
pembrolizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroblastoma
×
Bone Marrow Transplantation
×
90 days
×
Clear all
No trials found.